Many Psoriasis Patients Are Undertreated, Says Study
Many Psoriasis Patients Are Undertreated, Says Study
Filed under: drug treatment programs maryland
But even doctors with experience treating psoriasis may not be familiar with the constantly-evolving landscape of psoriasis treatment, according to Adam Friedman, MD, director of dermatologic research and associate residency program director at the …
Read more on Everyday Health
Altor BioScience Launches its Proprietary IL-15 Superagonist ALT-803 into …
Filed under: drug treatment programs maryland
Altor BioScience Corporation (Altor) a leading developer of immunotherapeutics announced today that the US Food and Drug Administration (FDA) has allowed the Investigational New Drug (IND) application for Altor‚Äôs novel interleukin-15 (IL-15 …
Read more on PharmiWeb.com (press release)
Titan Pharmaceuticals Announces Second Quarter 2013 Financial Results
Filed under: drug treatment programs maryland
On April 30, 2013, the FDA issued a Complete Response Letter (CRL) to Titan's NDA for Probuphine, an investigational, long-acting, subdermal implant formulation of buprenorphine for the maintenance treatment of adult patients with opioid dependence …
Read more on MarketWatch
Increasing Minority Participation in Clinical Trials
Filed under: drug treatment programs maryland
Earlier this month, Eli Lilly and the Center for Drug Development and Clinical Trials at the Roswell Park Cancer Institute (RCPI) unveiled a first-of-its-kind program aimed at training 75 to 150 minority oncologists in the conduct of clinical trials …
Read more on Genetic Engineering News